UK and US Regulatory Agencies Launch New Collaboration Program

The Medicines and Healthcare products Regulatory Agency in the UK and the U.S. Food and Drug Administration have announced a new liaison program. This initiative aims to enhance scientific exchange and improve collaboration between the two regulatory bodies. The program will establish dedicated officers to coordinate approaches on regulatory challenges and decisions, fostering safer product development.